Criticism has been raised that the government's policy to create global blockbuster drugs is not working and has a dark future.

It has been pointed out that the difficulty in raising funds to support the R&D costs for pharmaceutical and biotech companies and ventures is causing financial difficulties for bioventures, and that expert human resource training is not being done properly, either.

On the 17th, lawmaker In-soon Nam of the Democratic Party of Korea questioned Soon-do Cha, President of the Korea Health Industry Development Institute, about the policy direction of the pharmaceutical bio-industry during the National Assembly audit of the agency.

Rep Nam said